Howard Michelle, Aubrey-Bassler Kris, Drummond Neil, Lussier Marie-Thérèse, Queenan John A, Vanstone Meredith, Nicholson Kathryn, Ramdyal Amanda, Lawson Jennifer, Hafid Shuaib, Freeman Karla, Clark Rebecca, Mangin Dee
Department of Family Medicine, McMaster University, Hamilton, ON, Canada.
Primary Healthcare Research Unit, Memorial University of Newfoundland, St. John's, NL, Canada.
JMIR Res Protoc. 2023 Jul 21;12:e49131. doi: 10.2196/49131.
Since the COVID-19 pandemic began, there have been concerns that interruptions to the health care system may have led to changes in primary care, especially for care of chronic conditions such as diabetes and heart failure. Such changes may have longer term implications for population health.
This study aims to describe the impacts of the COVID-19 pandemic on indicators of primary care access, comprehensiveness, and appropriateness among adult patients, as well as on specific indictors of chronic conditions. Additionally, this study aims to determine whether any identified changes were associated with patient sociodemographic characteristics and multimorbidity.
This is a retrospective, single-arm, pre-post study using Canadian Primary Care Sentinel Surveillance Network (CPCSSN) data. CPCSSN is a research network supported by a primary care electronic medical record database, comprising over 1500 physicians and nearly 2 million patients. We are examining changes in care (eg, frequency of contacts, laboratory tests and investigations, referrals, medications prescribed, etc) among adults. We will also examine indicators specific to evidence-based recommendations for care in patients with diabetes and those with heart failure. We will compare rates of outcomes during key periods of the pandemic between March 13, 2020, and December 31, 2022, with equal time periods before the pandemic. Differences will be examined among specific subgroups of adults, including by decade of age, number of comorbidities, and socioeconomic status. Regression models appropriate to outcome distributions will be used to estimate changes, adjusting for potential confounders. This analysis is part of a mixed-methods study with a qualitative component investigating how patients with diabetes with or without concurrent heart failure perceived the impact of the pandemic on access to primary care and health care-related decisions. This study was approved by the Hamilton Integrated Research Ethics Board (14782-C).
The start date of this study was October 5, 2022, and the prospective end date is January 31, 2024. As of May 2023, the study cohort (n=875,934) is defined, data cleaning is complete, and exploratory analyses have begun. Extended analyses using 2022 data are planned once the new data becomes available. We will disseminate results through peer-reviewed publications and academic conference, as well as creating evidence briefs, infographics, and a video for policy maker and patient audiences.
This study will investigate whether the COVID-19 pandemic has resulted in changes in the provision of primary care in Canada and whether these potential changes have led to gaps in care. This study will also identify patient-level characteristics associated with changes in care patterns across the COVID-19 pandemic. Indicators specific to chronic conditions, namely diabetes and heart failure, will also be explored to determine whether there were changes in care of these conditions.
ClinicalTrials.gov NCT05813652; https://clinicaltrials.gov/ct2/show/NCT05813652.
INTERNATIONAL REGISTERED REPORT IDENTIFIER (IRRID): RR1-10.2196/49131.
自新冠疫情开始以来,人们一直担心医疗保健系统的中断可能导致初级保健发生变化,尤其是对糖尿病和心力衰竭等慢性病的护理。此类变化可能对人群健康产生长期影响。
本研究旨在描述新冠疫情对成年患者初级保健可及性、全面性和适宜性指标的影响,以及对慢性病特定指标的影响。此外,本研究旨在确定任何已识别的变化是否与患者的社会人口学特征和多病共存情况相关。
这是一项使用加拿大初级保健哨点监测网络(CPCSSN)数据的回顾性单臂前后对照研究。CPCSSN是一个由初级保健电子病历数据库支持的研究网络,包括1500多名医生和近200万患者。我们正在研究成年人护理方面的变化(如就诊频率、实验室检查和调查、转诊、所开药物等)。我们还将研究针对糖尿病患者和心力衰竭患者循证护理建议的特定指标。我们将比较2020年3月13日至2022年12月31日疫情关键时期的结果发生率与疫情前相同时间段的结果发生率。将在特定成年亚组中进行差异分析,包括按年龄十年分组、共病数量和社会经济地位分组。将使用适合结果分布的回归模型来估计变化,并对潜在混杂因素进行调整。该分析是一项混合方法研究的一部分,该研究的定性部分调查了合并或未合并心力衰竭的糖尿病患者如何看待疫情对获得初级保健和医疗保健相关决策的影响。本研究已获得汉密尔顿综合研究伦理委员会(14782-C)的批准。
本研究的开始日期为2022年10月5日,预期结束日期为2024年1月31日。截至2023年5月,研究队列(n = 875934)已确定,数据清理已完成,探索性分析已开始。一旦新数据可用,计划使用2022年数据进行扩展分析。我们将通过同行评审出版物和学术会议传播结果,以及为政策制定者和患者受众制作证据摘要、信息图表和视频。
本研究将调查新冠疫情是否导致加拿大初级保健服务发生变化,以及这些潜在变化是否导致了护理差距。本研究还将确定与新冠疫情期间护理模式变化相关的患者层面特征。还将探索糖尿病和心力衰竭等慢性病的特定指标,以确定这些疾病的护理是否发生了变化。
ClinicalTrials.gov NCT05813652;https://clinicaltrials.gov/ct2/show/NCT05813652。
国际注册报告识别码(IRRID):RR1-10.2196/49131。